Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 7189827 Modified peptides as therapeutic agents

Patent 7189827 was granted and assigned to Amgen on March, 2007 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributorsActivity

All edits

Edits on 15 May, 2024
"update inverses"
Golden AI profile picture
Golden AI
edited on 15 May, 2024
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
‌
US Patent 11981718 Dual-function protein for lipid and blood glucose regulation
0
Edits on 7 Dec, 2023
"update inverses"
Golden AI profile picture
Golden AI
edited on 7 Dec, 2023
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
‌
US Patent 11833212 Linker peptide for constructing fusion protein
0
Edits on 6 Sep, 2023
"Add patent inventor(s)"
Golden AI profile picture
Golden AI
edited on 6 Sep, 2023
Edits made to:
Infobox (+1 properties)
Infobox
Patent Inventor Names
Ulrich Feige0
Edits on 1 Sep, 2023
"Add patent abstract"
Golden AI profile picture
Golden AI
edited on 1 Sep, 2023
Edits made to:
Article (+497 characters)
Article

Patent abstract

The present invention concerns fusion of Fc domains with biologically active peptides and a process for preparing pharmaceutical agents using biologically active peptides. In this invention, pharmacologically active compounds are prepared by a process comprising:a) selecting at least one peptide that modulates the activity of a protein of interest; andb) preparing a pharmacologic agent comprising an Fc domain covalently linked to at least one amino acid of the selected peptide.

Edits on 28 Jun, 2023
"update inverses"
Golden AI profile picture
Golden AI
edited on 28 Jun, 2023
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
‌
US Patent 11685770 Stabilized receptor polypeptides and uses thereof
0
Edits on 21 May, 2023
"Remove leading 0 from patent number"
Golden AI profile picture
Golden AI
edited on 21 May, 2023
Edits made to:
Infobox (+1/-1 properties)
‌

US Patent 07189827 Modified peptides as therapeutic agents US Patent 7189827 Modified peptides as therapeutic agents

Infobox
Patent Number
071898270
Patent Number
71898270
Edits on 20 May, 2023
"Remove website redirecting to Patent Public Search front page"
Golden AI profile picture
Golden AI
edited on 20 May, 2023
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
https://pdfpiw.uspto.gov/.piw?Docid=071898270
Edits on 2 Apr, 2023
"Entity importer update"
Golden AI profile picture
Golden AI
edited on 2 Apr, 2023
Infobox
Is a
Patent
Patent
0
Current Assignee
Amgen
Amgen
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
071898270
Date of Patent
March 13, 2007
0
Patent Application Number
106323880
Date Filed
July 31, 2003
0
Official Website
https://pdfpiw.uspto.gov/.piw?Docid=071898270
Patent Primary Examiner
‌
Sheela J. Huff
0
Edits on 8 Jun, 2022
"Entity importer update"
Golden AI profile picture
Golden AI
edited on 8 Jun, 2022
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
https://pdfpiw.uspto.gov/.piw?Docid=07189827
Edits on 20 Nov, 2021
"Created via: Entity Importer"
Golden AI profile picture
Golden AI
created this topic on 20 Nov, 2021
Edits made to:
Infobox (+8 properties)
‌

 US Patent 07189827 Modified peptides as therapeutic agents

Infobox
Is a
Patent
Patent
Current assignee
Amgen
Amgen
Patent jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
Patent number
07189827
Date of patent
March 13, 2007
Patent application number
10632388
Date Filed
July 31, 2003
Patent primary examiner
‌
Sheela J. Huff

Find more entities like US Patent 7189827 Modified peptides as therapeutic agents

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo